Business Daily Media

The Times Real Estate

.

Cardinal Health acquires smart prescription platform ScalaMed


Cardinal Health (NYSE:CAH) announced the acquisition of ScalaMed, a HIPAA-compliant, smart platform that transfers prescriptions directly to patients via a secure mobile app. The acquisition transfers ScalaMed’s technology and assets to Outcomes™, a Cardinal Health company.

ScalaMed pivots prescription management from provider to patient, allowing patients to send prescriptions written by their provider directly to any pharmacy for the first fill. The platform offers patients greater flexibility, easier access, and price comparison to select the pharmacy of their choice.

For providers, the platform eliminates the administrative work of transferring prescriptions, saving the average clinician 40 hours per year, and helps improve health outcomes with improved adherence, and increased patient satisfaction. Scalamed’s technology will be offered through the Cardinal Health nationwide pharmacy network, creating unprecedented opportunities for digital connectivity to millions of patients.

“As healthcare continues to evolve toward patient preferences, the acquisition of ScalaMed allows us to center our connected ecosystem around the patient from the outset of their treatment journey - from the doctor’s office to the pharmacy to home,” said Brent Stutz, SVP/GM of Outcomes™, a Cardinal Health Company. “Using ScalaMed’s technology, we can better support patients at every step along their treatment journey through unified communication and more informed insights that will help remove access and adherence barriers.”

Built by physicians and pharmacists with first-hand knowledge of how prescriptions are often mismanaged in the current healthcare system, ScalaMed worked to develop a digital solution that empowered patients and personalized their care, taking into account the real-world challenges of daily life that often lead to medication nonadherence.

“The process of digitizing prescriptions removes the patient from the equation and overlooks the complexity of the real-life adherence challenges patients face – forgetting medication on vacation, not having a pharmacy with convenient hours nearby, the variables are endless,” said Dr. Tal Rapke, MD CEO and Founder of ScalaMed. “We’re excited to partner with a leader in pharmacy like Cardinal Health, so that together, we can offer a solution that is both smart and patient-centric. With the scale and innovation Cardinal Health offers, we can revolutionize how prescriptions are filled and help solve the massive, costly challenge of medication nonadherence.”

Retailers combat post-Christmas debt and boost revenue amid changing customer behaviours

As the festive season wraps up, Australian retailers and companies are shifting their focus from holiday sales to addressing the challenges of pos...

When Will Infrastructure Companies See Gains from Generative AI?

A lot of questions are swirling about the state of generative AI right now. How far along are companies with their bespoke GenAI efforts? Are orga...

DLPA partners with Crestcom to bring its leadership training solutions

Dynamic Leadership Programs Australia (DLPA), a leading provider of leadership training and workforce strategy solutions, has joined forces with r...

Infosys and Tennis Australia Create New Generative AI Innovations at the Australian Open 2025

Infosys (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting, in partnership with Tennis Australia, has unv...

UBH Group Pioneers Australia's Path to Nuclear Sovereignty

Sovereign technology company, UBH Group, has achieved a landmark milestone as the first organisation in the Southern Hemisphere to secure ISO 1944...

The unsung heroes: How MSPs can safeguard SMBs while boosting profitability

In Australia, small-to-medium-sized businesses (SMBs) form the backbone of the economy, accounting for 95% of all businesses. Yet, they remain pri...

Sell by LayBy